Dr. Pedro Jose Ruiz, MD, PhD

Dr. Ruiz practices at California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California.

Dr. Ruiz's NPI, 1023204468, was assigned on September 19, 2007. Dr. Ruiz graduated from Pontifical Xavierian University in 1984. Dr. Ruiz holds California license A84199.

Dr. Ruiz's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD, at 2333 Buchanan St, San Francisco, CA 94115.

Dr. Ruiz's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California. Dr. Ruiz is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is San Francisco International Airport (SFO) Medical Clinic. Dmand AI also links Dr. Ruiz to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ruiz practices, 6 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Ruiz's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Ruiz is board certified in internal medicine by the American Board of Internal Medicine. Dr. Ruiz is licensed in California.

Dmand AI lists arteritis, arthritis, carpal tunnel syndrome, cirrhosis of the liver, fibromyalgia and chronic pain, fluid in a joint, gout and immune deficiency disease among the conditions Dr. Ruiz treats.

CMS data shows 401 Medicare services from Dr. Ruiz across 5 procedure codes in 2024, for 137 Medicare patients. Medicare paid $34,233 for them. Every service was in an office.

CMS counts 137 Medicare patients who saw Dr. Ruiz in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have arthritis, and 74% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ruiz's median patient age at 71, with 61% women.

In 2024, Dr. Ruiz wrote 738 Medicare Part D claims for 138 patients. 73% of them were for generic drugs. CMS names the drug for 623 of them, across 11 drugs with 11 or more claims each, at $1,038,508 in total drug cost. In 2023, CMS named 613 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Ruiz for performance year 2024, reported as part of a group. Dr. Ruiz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ruiz as offering telehealth.

Dmand AI links 21 papers to Dr. Ruiz, published from 2003 to 2012. 2012 was the busiest year, with 2. The most frequent topics are Amino Acid Sequence, Antibodies, Monoclonal and Lupus Erythematosus, Systemic. Dr. Ruiz has published most often in J Immunol. Dr. Ruiz's most frequent co-authors are Lawrence Steinman, MD, Hideki Garren, MD and William Hewitt Robinson, MD.

CMS Open Payments shows 74 general payments to Dr. Ruiz from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $649.

Dmand AI lists 2 awards for Dr. Ruiz.

Dr. Ruiz graduated from Pontifical Xavierian University in 1984. Dr. Ruiz is a member of ACP and ACR.

Dr. Ruiz is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.